Kbc Group Nv PROGENICS PHARMACEUTICALS IN Transaction History

Kbc Group Nv

  • $36.3 Billion
  • Q4 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020
SELL
N/A
-12,732 Closed
0 $0
Q4 2019

Feb 11, 2020
BUY
N/A
12,707 Added 50828.0%
12,732 $65,000
Q3 2019

Nov 07, 2019
SELL
N/A
-22,147 Reduced 99.89%
25 $0
Q2 2019

Dec 03, 2019
BUY
N/A
22,172 New
22,172 $137,000
Q2 2019

Jul 30, 2019
SELL
N/A
-22,172 Closed
0 $0
Q1 2019

Dec 03, 2019
BUY
N/A
22,172 New
22,172 $103,000
Q1 2019

May 10, 2019
SELL
N/A
-19,472 Closed
0 $0
Q4 2018

Dec 03, 2019
BUY
N/A
19,472 New
19,472 $82,000
Q4 2018

Jan 31, 2019
SELL
N/A
-19,472 Closed
0 $0
Q3 2018

Dec 03, 2019
SELL
N/A
-309,259 Reduced 94.08%
19,472 $122,000
Q3 2018

Nov 14, 2018
BUY
N/A
110,108 Added 50.36%
328,731 $0
Q1 2018

May 09, 2018
BUY
N/A
1,051 Added 0.48%
218,623 $0
Q4 2017

Feb 07, 2018
SELL
N/A
-17,205 Reduced 7.33%
217,572 $0
Q3 2017

Nov 13, 2017
BUY
N/A
234,777
234,777 $0
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email